Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 66.7%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 33.3%High 0 · 0%

Tocilizumab every 4 weeks vs placebo

Mean time to first relapse after induction of remission (weeks) at ≥ 12 months · adults aged over 50 years with giant cell arteritis

Tocilizumab every 4 weeks probably leads to higher mean time to first relapse after induction of remission (weeks) at ≥… compared with placebo (moderate certainty).

1 finding from 1 review

Tocilizumab for giant cell arteritis 2022 · Cochrane Headline outcomes only
MD 25 [11.4, 38.6]
1 study · 30 participants
Moderate

Tocilizumab every other week vs placebo + 52‐week taper

Mean time to first relapse after induction of remission (weeks) at ≥ 12 months · adults aged over 50 years with giant cell arteritis

The review found no eligible studies for this question.

1 finding from 1 review

Tocilizumab for giant cell arteritis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tocilizumab every other week vs placebo + 26‐week taper

Mean time to first relapse after induction of remission (weeks) at ≥ 12 months · adults aged over 50 years with giant cell arteritis

The review found no eligible studies for this question.

1 finding from 1 review

Tocilizumab for giant cell arteritis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found